Average Co-Inventor Count = 4.27
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. N30 Pharmaceuticals, Inc. (7 from 17 patents)
2. Nivalis Therapeutics, Inc. (5 from 19 patents)
3. Rxkinetix, Inc. (3 from 6 patents)
4. Endo Pharmaceuticals Inc. (1 from 32 patents)
5. Endo Pharmaceuticals Colorado, Inc. (1 from 2 patents)
6. Vasogenix Pharmaceuticals, Inc. (1 from 2 patents)
18 patents:
1. 9814700 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
2. 9498466 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
3. 9180119 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
4. 9138427 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
5. 9029402 - Pyrrole inhibitors of S-nitrosoglutathione reductase
6. 8957105 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
7. 8846736 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
8. 8691816 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
9. 8686015 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
10. 8673961 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
11. 8642628 - Pyrrole inhibitors of S-nitrosoglutathione reductase
12. 8470857 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
13. 7767197 - Delivery vehicle composition and methods for delivering antigens and other drugs
14. 7501452 - Treatment of xerostomia
15. 6875441 - Composition for delivery of hematopoietic growth factor